Valuation : COMPASS Pathways plc

Market Cap 2.02B 1.74B 1.63B 1.49B 2.81B 193B 2.82B 19.29B 7.47B 97.35B 7.6B 7.43B 322B P/E 2026 *
-6.79x
P/E 2027 * -8.72x
Enterprise Value 1.66B 1.43B 1.34B 1.22B 2.31B 159B 2.32B 15.87B 6.15B 80.07B 6.25B 6.11B 265B EV / Sales 2026 *
-
EV / Sales 2027 * 40.1x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day-1.81%
1 week+4.28%
Current month+28.72%
1 month+29.75%
3 months+19.51%
6 months+99.32%
Current year+111.74%
1 week 13.08
Extreme 13.08
15.01
1 month 10.59
Extreme 10.59
15.01
Current year 4.88
Extreme 4.88
15.4
1 year 4.4
Extreme 4.4
15.4
3 years 2.25
Extreme 2.25
15.4
5 years 2.25
Extreme 2.25
49.52
10 years 2.25
Extreme 2.25
61.69
Manager TitleAgeSince
Chief Executive Officer 61 31/07/2022
Director of Finance/CFO 54 29/02/2024
Chief Tech/Sci/R&D Officer 66 30/04/2024
Director TitleAgeSince
Chairman 74 28/03/2024
Director/Board Member 69 31/03/2020
Director/Board Member 67 28/02/2021
Date Insider Type Main position Quantity % Market Cap.
03/08/26 Tax

Chief Executive Officer

-5,962 0.0062%
26/03/26 Free

Chief Executive Officer

542,815 0.5658%
11/03/26 Tax

Chief Financial Officer

1,781 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
-1.81%+4.28%+206.93%+62.88% 2.02B
-0.20%+0.31%+2.66%+23.58% 50.96B
+1.92%+0.36%+477.97%+550.09% 46.18B
-0.15%-0.28%+21.65%+89.41% 42.73B
+0.81%+4.91%+39.28%+19.41% 43.04B
-2.27%-3.02%+14.22%+51.50% 33.48B
+0.81%+1.77%+31.91%+138.26% 17.28B
-1.08%-3.61% - - 16.43B
-0.49%-0.49%+11.20%+27.93% 14.73B
-0.85%+1.76%+80.26%+47.26% 14.09B
Average -0.57%+1.63%+98.45%+112.26% 28.09B
Weighted average by Cap. -0.38%+1.18%+104.21%+138.28%

Financials

2026 *2027 *
Net sales - 39.7M 34.07M 31.98M 29.21M 55.12M 3.79B 55.39M 378M 147M 1.91B 149M 146M 6.33B
Net income -299M -256M -241M -220M -415M -28.48B -417M -2.85B -1.1B -14.37B -1.12B -1.1B -47.58B -252M -216M -203M -185M -350M -24.02B -351M -2.4B -931M -12.12B -946M -925M -40.14B
Net Debt -359M -308M -289M -264M -499M -34.24B -501M -3.42B -1.33B -17.27B -1.35B -1.32B -57.21B -432M -371M -348M -318M -600M -41.22B -603M -4.12B -1.6B -20.79B -1.62B -1.59B -68.87B
Logo COMPASS Pathways plc
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Employees
156
Date Price Change Volume
26/08/26 US$14.61 -1.81% 1,744,745
25/08/26 US$14.88 +4.79% 2,282,110
24/08/26 US$14.20 +6.53% 2,776,364
21/08/26 US$13.33 -3.55% 2,084,620
20/08/26 US$13.82 -1.36% 2,038,389
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
14.61USD
Average target price
23.75USD
Spread / Average Target
+62.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CMPS Stock